Different combination schedules of gemcitabine with endostar affect antitumor efficacy

Cancer Chemotherapy and Pharmacology

Volumn 69, Issue 1, 2012, Pages 239-246

  Peng, Xing Chen ^a,b   Qiu, Meng ^a   Wei, Meng ^a   Tan, Ben Xu ^a   Ge, Jun ^a   Zhao, Yu ^a   Chen, Ye ^a   Cheng, Ke ^a   Zhou, Yi ^a   Wu, Yang ^a   Gong, Feng Ming ^a   Li, Qiu ^a   Xu, Feng ^a   Bi, Feng ^a   Liu, Ji Yan ^a  

^a SICHUAN UNIVERSITY   (China)

^b GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Antiangiogenesis; Combined therapy; Endostatin; Gemcitabine; VEGF

Indexed keywords

GEMCITABINE; RECOMBINANT ENDOSTATIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL LEVEL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INHIBITION; DRUG MEGADOSE; DRUG SCREENING; LEWIS CARCINOMA; MONOTHERAPY; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARCINOMA, LEWIS LUNG; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; ENDOSTATINS; MICE; MICE, INBRED C57BL; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84856750367     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-011-1695-8     Document Type: Article

References (37)

1. J Folkman 2002 Role of angiogenesis in tumor growth and metastasis Semin Oncol 29 15 18 12516034 1:CAS:528:DC%2BD3sXlvFSqtg%3D%3D
2. W Risau 1997 Mechanisms of angiogenesis Nature 386 671 674 9109485 10.1038/386671a0 1:STN:280:DyaK2s3mtlGksg%3D%3D (Pubitemid 27193480)
3. M Kirsch G Schackert PM Black 2000 Angiogenesis, metastasis, and endogenous inhibition J Neurooncol 50 173 180 11245277 10.1023/A:1006453428013 1:STN:280:DC%2BD3Mzmsl2luw%3D%3D (Pubitemid 32166299)
4. A Tandle DG Blazer III SK Libutti 2004 Antiangiogenic gene therapy of cancer: recent developments J Transl Med 2 22 15219236 10.1186/1479-5876-2-22 (Pubitemid 39130350)
5. W Arap R Pasqualini E Ruoslahti 1998 Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 377 380 9430587 10.1126/science.279.5349.377 1:CAS:528:DyaK1cXmtl2juw%3D%3D (Pubitemid 28063372)
6. M Gourley JS Williamson 2000 Angiogenesis: new targets for the development of anticancer chemotherapies Curr Pharm Des 6 417 439 10788590 10.2174/1381612003400867 1:CAS:528:DC%2BD3cXjt1Cltb0%3D (Pubitemid 30396405)
7. J Folkman D Hanahan 1991 Switch to the angiogenic phenotype during tumorigenesis Princess Takamatsu Symp 22 339 347 1726933 1:STN:280: DyaK3s3gtlWhtw%3D%3D
8. M Dhanabal R Ramchandran MJF Waterman LU Hua B Knebelmann M Segal VP Sukhatme 1999 Endostatin induces endothelial cell apoptosis J Biol Chem 274 11721 11726 10206987 10.1074/jbc.274.17.11721 1:CAS:528:DyaK1MXislGlsrk%3D (Pubitemid 29197835)
9. J Dixelius M Cross T Matsumoto T Sasaki R Timpl L Claesson-Welsh 2002 Endostatin regulates endothelial cell adhesion and cytoskeletal organization Cancer Res 62 1944 1947 11929807 1:CAS:528:DC%2BD38XivVyltLY%3D (Pubitemid 34408434)
10. YM Kim S Hwang YM Kim BJ Pyun TY Kim ST Lee YS Gho YG Kwon 2002 Endostatin blocks VEGF-mediated signaling via direct interaction with KDR/Flk-1 J Biol Chem 277 27872 27879 12029087 10.1074/jbc.M202771200 1:CAS:528: DC%2BD38XlvFKgt74%3D (Pubitemid 34966733)
11. I Ding JZ Sun B Fenton WM Liu P Kimsely P Okunieff W Min 2001 Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas Cancer Res 61 526 531 11212245 1:CAS:528:DC%2BD3MXht1Gms7Y%3D (Pubitemid 32128611)
12. BV Sauter O Martinet WJ Zhang J Mandeli SLC Woo 2000 Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases Proc Natl Acad Sci USA 97 4802 4807 10758166 10.1073/pnas.090065597 1:CAS:528:DC%2BD3cXivFKjur8%3D (Pubitemid 30238638)
13. T Boehm J Folkman T Browder MS O'Reilly 1997 Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390 404 407 9389480 10.1038/37126 1:CAS:528:DyaK2sXns12rsL8%3D (Pubitemid 28027321)
14. RS Herbst AT Lee HT Tran JL Abbruzzese 2001 Clinical studies of angiogenesis inhibitors: the University of Texas MD Anderson Center Trial of Human Endostatin Curr Oncol Rep 3 131 140 11177745 10.1007/s11912-001-0013-8 1:STN:280:DC%2BD3M7psVyquw%3D%3D
15. T Browder CE Butterfield BM Kräling B Shi B Marshall MS O'Reilly J Folkman 2000 Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer Cancer Res 60 1878 1886 10766175 1:CAS:528:DC%2BD3cXisVynurk%3D (Pubitemid 30207647)
16. L Bello G Carrabba C Giussani V Lucini F Cerutti F Scaglione J Landré M Pluderi G Tomei R Villani, et al. 2001 Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo Cancer Res 61 7501 7506 11606386 1:CAS:528:DC%2BD3MXnvFShsLc%3D (Pubitemid 32995040)
17. PV Dickson JB Hamner TL Sims CH Fraga CY Ng S Rajasekeran NL Hagedorn MB McCarville CF Stewart AM Davidoff 2007 Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy Clin Cancer Res 13 3942 3950 17606728 10.1158/1078-0432.CCR-07-0278 1:CAS:528:DC%2BD2sXntFymt7o%3D (Pubitemid 47037602)
18. B Arup S Mukund DO Steven T Károly MV Mary MR Youcef 2008 Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer Drugs Clin Cancer Res 14 3926 3932 10.1158/1078-0432.CCR-08-0212
19. M Jie JW David 2008 Combination of antiangiogenesis with chemotherapy for more effective cancer treatment Mol Cancer Ther 7 3670 3684 10.1158/1535-7163.MCT-08-0715
20. PMD Ruud L Melissa H Hanke E McNiel AW Griffioen KH Mayo RJ Griffin 2007 Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization Clin Cancer Res 13 3395 3402 10.1158/1078-0432.CCR-06-2441 (Pubitemid 46944928)
21. H Jia J Kling 2006 China offers alternative gateway for experimental drugs Nat Biotechnol 24 117 118 16465139 10.1038/nbt0206-117 1:CAS:528:DC%2BD28XhtFGrtbg%3D (Pubitemid 43221686)
22. HF Song XW Liu HN Zhang BZ Zhu SJ Yuan SY Liu ZM Tang 2005 Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys Acta Pharmacol Sin 26 124 128 15659125 10.1111/j.1745-7254.2005.00009.x 1:CAS:528:DC%2BD2MXptFKjsw%3D%3D (Pubitemid 40093250)
23. W Shi Q Tang X Chen P Cheng P Jiang X Jing X Chen P Chen Y Wang Y Wei, et al. 2009 Antitumor and antimetastatic activities of vesicular stomatitis virus matrix protein in a murine model of breast cancer J Mol Med 87 493 506 19259640 10.1007/s00109-009-0444-5 1:CAS:528:DC%2BD1MXkvV2jsbo%3D
24. JM Hou JY Liu L Yang X Zhao L Tian ZY Ding YJ Wen T Niu F Xiao YY Lou, et al. 2005 Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities Oncology 69 81 87 16088235 10.1159/000087303 1:CAS:528: DC%2BD2MXoslKgt70%3D (Pubitemid 41207061)
25. N Weidner JP Semple WR Welch J Folkman 1991 Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma N Eng J Med 324 1 8 10.1056/NEJM199101033240101 1:STN:280:DyaK3M%2FnsVWquw%3D%3D
26. L Rosen 2000 Antiangiogenic strategies and agents in clinical trials Oncologist 5 20 27 10804087 10.1634/theoncologist.5-suppl-1-20 1:CAS:528:DC%2BD3cXjsFartrs%3D (Pubitemid 30225453)
27. R Longo R Sarmiento M Fanelli B Capaccetti D Gattuso G Gasparini 2002 Anti-angiogenic therapy: rationale, challenges and clinical studies Angiogenesis 5 237 256 12906317 10.1023/A:1024532022166 1:CAS:528:DC%2BD3sXltFynsLY%3D (Pubitemid 36875123)
28. S Calatayud TD Warner JA Mitchell 2002 Modulation of colony stimulating factor release and apoptosis in human colon cancer cells by anticancer drugs Br J Cancer 86 1316 1321 11953891 10.1038/sj.bjc.6600240 1:CAS:528: DC%2BD38XksVSmtLY%3D
29. L Geng E Donnelly G McMahon PC Lin E Sierra-Rivera H Oshinka DE Hallahan 2001 Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy Cancer Res 61 2413 2419 11289107 1:CAS:528:DC%2BD3MXisVSlurg%3D (Pubitemid 32685816)
30. DH Gorski MA Beckett NT Jaskowiak DP Calvin HJ Mauceri RM Salloum S Seetharam A Koons DM Hari DW Kufe, et al. 1999 Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation Cancer Res 59 3374 3378 10416597 1:CAS:528:DyaK1MXks1Oms7s%3D (Pubitemid 29334495)
31. AP Taylor L Ososrio R Craig JA Raleigh Z Ying DM Goldenberg RD Blumenthal 2002 Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy Clin Cancer Res 8 1213 1222 11948135 1:CAS:528:DC%2BD38XjsF2ltL8%3D (Pubitemid 35177377)
32. J Wang P Lou R Lesniewski J Henkin 2003 Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly Anticancer Drugs 14 13 19 12544254 10.1097/00001813-200301000-00003 (Pubitemid 36177350)
33. CJ Sweeney KD Miller SE Sissons S Nozaki DK Heilman J Shen GW Sledge Jr 2001 The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors Cancer Res 61 3369 3372 11309294 1:CAS:528:DC%2BD3MXjtFSjur4%3D (Pubitemid 32695027)
34. Y Miyahara S Yoshida S Motoyama Y Tateiwa S Hamana T Maruo 2004 Effect of cis-diammine dichloroplatinum on vascular endothelial growth factor expression in uterine cervical carcinoma Eur J Gynaecol Oncol 25 33 39 15053059 1:STN:280:DC%2BD2c7lvFantg%3D%3D (Pubitemid 38165917)
35. F Riedel K Götte U Goessler H Sadick K Hörmann 2004 Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines Anticancer Res 24 2179 2183 15330158 1:CAS:528: DC%2BD2cXot1CgtLY%3D (Pubitemid 39166292)
36. DC Lev M Ruiz L Mills EC McGary JE Price M Bar-Eli 2003 Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy Mol Cancer Ther 2 753 763 12939465 1:CAS:528:DC%2BD3sXms1GktLY%3D
37. PJ Mills B Parker V Jones KA Adler CJ Perez S Johnson M Cohen-Zion M Marler GR Sadler JE Dimsdale, et al. 2004 The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer Clin Cancer Res 10 4998 5003 15297400 10.1158/1078-0432.CCR-0734-04 1:CAS:528:DC%2BD2cXmtlSitrg%3D (Pubitemid 39099773)